Premium
Oruka Therapeutics Inc (ORKA)
NASDAQ
Hot Features
Inscrivez-vous pour des graphiques en temps réel, des outils d'analyse et des prix.
Pharmacokinetic and safety data from healthy volunteers anticipated in the second half of 2025 On track to initiate a proof-of-concept study in psoriasis in the second half of 2025, with initial...
MENLO PARK, Calif., Dec. 18, 2024 (GLOBE NEWSWIRE) -- Oruka Therapeutics, Inc. (“Oruka”) (Nasdaq: ORKA), a biotechnology company developing novel biologics designed to set a new standard for the...
MENLO PARK, Calif., Nov. 19, 2024 (GLOBE NEWSWIRE) -- Oruka Therapeutics, Inc. (“Oruka”) (Nasdaq: ORKA), a biotechnology company developing novel biologics designed to set a new standard for the...
| Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | -1.98 | -8.5677196019 | 23.11 | 23.57 | 19.8375 | 937234 | 20.86694084 | CS |
| 4 | 1.76 | 9.08621579763 | 19.37 | 25.65 | 18.2 | 392112 | 21.35297156 | CS |
| 12 | -3.63 | -14.6607431341 | 24.76 | 31.13 | 18.2 | 222629 | 23.1048301 | CS |
| 26 | -4.37 | -17.137254902 | 25.5 | 31.13 | 18.2 | 181673 | 23.24747078 | CS |
| 52 | -4.37 | -17.137254902 | 25.5 | 31.13 | 18.2 | 181673 | 23.24747078 | CS |
| 156 | -4.37 | -17.137254902 | 25.5 | 31.13 | 18.2 | 181673 | 23.24747078 | CS |
| 260 | -4.37 | -17.137254902 | 25.5 | 31.13 | 18.2 | 181673 | 23.24747078 | CS |
| Aucune Discussion Trouvée |
| Ajouter une Discussion |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
